Kazmirski S L, Wong K B, Freund S M, Tan Y J, Fersht A R, Daggett V
Department of Medicinal Chemistry, University of Washington, Seattle, WA 98195-7610, USA.
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4349-54. doi: 10.1073/pnas.071054398. Epub 2001 Mar 27.
Previous experimental and theoretical studies have produced high-resolution descriptions of the native and folding transition states of chymotrypsin inhibitor 2 (CI2). In similar fashion, here we use a combination of NMR experiments and molecular dynamics simulations to examine the conformations populated by CI2 in the denatured state. The denatured state is highly unfolded, but there is some residual native helical structure along with hydrophobic clustering in the center of the chain. The lack of persistent nonnative structure in the denatured state reduces barriers that must be overcome, leading to fast folding through a nucleation-condensation mechanism. With the characterization of the denatured state, we have now completed our description of the folding/unfolding pathway of CI2 at atomic resolution.
先前的实验和理论研究已经对胰凝乳蛋白酶抑制剂2(CI2)的天然态和折叠过渡态进行了高分辨率描述。以类似的方式,我们在这里结合核磁共振实验和分子动力学模拟,来研究CI2在变性状态下的构象。变性状态是高度解折叠的,但在链的中心存在一些残留的天然螺旋结构以及疏水簇集。变性状态下缺乏持久的非天然结构减少了必须克服的障碍,导致通过成核-凝聚机制快速折叠。随着对变性状态的表征,我们现在已经完成了对CI2折叠/解折叠途径的原子分辨率描述。